Robert Azelby

ADCT

Robert Azelby serves as Director at ADC Therapeutics S.A. (ADCT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$65.3K

Net Position

Net Seller

$65.3K

Companies Traded

ADCT

Active Period

Jun 2024 – Jun 2025

2 total trades

Most Recent

Sell ADCT

Jun 13, 2025 · $45.1K

Robert Azelby's Insider Trading at ADC Therapeutics S.A. (ADCT)

Buys

0 · $0.00

Sells

2 · $65.3K

Total Shares Bought

Total Shares Sold

19,595

ADCT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 13, 2025↗	Sell	12,600	$3.58	$45.1K	0
Jun 17, 2024↗	Sell	6,995	$2.89	$20.2K	0

Related Insiders

Mohamed Zaki

Chief Medical Officer

ADCTSell · Feb 13, 2026

Jose Carmona

Chief Financial Officer

ADCTSell · Feb 13, 2026

GRAHAM PETER J

Chief Legal Officer

ADCTSell · Feb 13, 2026

Lisa Michelle Kallebo

Chief Accounting Officer

ADCTSell · Feb 13, 2026

MALLIK AMEET

Chief Executive Officer

ADCTSell · Feb 13, 2026

BIZZARI JEAN-PIERRE

Director

ADCTSell · Jun 13, 2025

Viviane Monges

Director

ADCTSell · Jun 13, 2025

Victor Sandor

Director

ADCTSell · Jun 13, 2025

Explore More Insider Trading Data

ADCT Insider Trading Activity

View all insider trades at ADC Therapeutics S.A.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity